Steris opened higher at $233.98, compared with its previous close of $232.14. In the last trading session, the stock traded between $227.46 and $233.98. It showed a downward intraday trend.
return calculator
Time Period
An investment of $100 made 5 years ago in Steris is now worth
$ 97.44
resulting in a loss of
$ 2.56 (2.56%)
invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 4 Analysts
Buy
75%
Hold
25%
Sell
0%
Markets Today
Today's Change
$-4.38 (-1.89%)
Day High
$233.98
Day Low
$227.46
Day Open
$233.98
Prev Close
$232.14
Volume
2,88,951
1W Return
-1.89%
1M Return
8.13%
3M Return
-3.01%
6M Return
7.11%
1Y Return
-3.81%
Fundamentals
Market Cap ($ Mn)
22,207
PE Ratio
28.58
PB Ratio
3.16
PEG Ratio
1.46
ROE
9.48%
ROCE
9.28%
EPS (TTM)
$2.05
Investment Returns
1 Week
-1.89%
1 Month
8.13%
3 Months
-3.01%
6 Months
7.11%
9 Months
-12.95%
Financials
Quarterly
All values in $ Mn
1.5K
Mar 25
1.4K
Jun 25
1.5K
Sep 25
1.5K
Dec 25
1.6K
Mar 26
1.5K
Jun 26
Updates
29Oct
Steris declares $0.69 per share quarterly dividend for Q4 2026
Steris plc declared a quarterly dividend of $0.69 per share. Shareholders of record on November 17, 2026 are eligible for the payout. Dividend payment date is set for December 17, 2026.
Yesterday
21Oct
Steris plc to host Q2FY27 earnings conference call on Nov 5
Steris plc will host a conference call for Q2FY27 results on November 5, 2026. Financial press release to be issued after market close on November 4, 2026. Replay available from 12:00 pm ET on November 5, 2026.
9 days ago
2Sep
STERIS CEO Dan Carestio to present at Morgan Stanley Healthcare Conference
STERIS CEO Dan Carestio to present at Morgan Stanley Healthcare Conference. Presentation scheduled for September 15, 2026, at 1:05 pm ET in New York. Webcast and replay available on investor relations website.
STERIS plc delivered Q1 FY27 revenue of $1.5 billion, up 7% YoY, with net income reaching $200.1 million. The Healthcare segment drove growth with an 8% revenue increase. The company announced a restructuring plan for a new North Carolina facility, leading to revised capital expenditure and free cash flow guidance for fiscal 2027.
Steris updates its FY2027 financial outlook by widening adjusted EPS guidance to $11.00-$11.30 while affirming GAAP EPS at $9.00-$9.20. Sales guidance remains unchanged at $6.35B-$6.41B.
2mo ago
5Aug
STERIS invests $600 million in North Carolina manufacturing hub
STERIS plc is investing $600 million to build a new manufacturing and distribution Center of Excellence in North Carolina. Located near the Raleigh-Durham Research Triangle, the facility will produce infection prevention and contamination control chemistries for Healthcare and Pharmaceutical industries, strengthening the company's domestic supply chain and production capabilities.
